Test Price
700 AEDโ Home Collection Available
Epstein-Barr Virus (EBV) RNA Qualitative Detection in UAE | 700 AED | DHA Licensed
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation.
Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The Epstein-Barr Virus (EBV) RNA Qualitative Detection assay identifies active viral replication by detecting viral RNA via Real-Time PCR and Whole Genome Sequencing, enabling precise diagnosis of acute infectious mononucleosis, EBV-associated malignancies, and monitoring of immunocompromised patients. This test is essential for differentiating primary infection from reactivation and guiding targeted therapy.
| Feature | EBV RNA Qualitative Detection | Standard EBV Antibody Panel (IgM/IgG) |
|---|---|---|
| Methodology | Real-Time PCR & Whole Genome Sequencing (Direct viral RNA) | Serological immunoassay (indirect immune response) |
| Clinical Sensitivity | >99.9% for active replication | ~85% (cross-reactivity, false negatives in early phase) |
| Turnaround Time | 3rd Working Day (Expedited Email: 36 hours; Phone: 24 hours) | 5โ7 working days |
| Clinical Relevance | Detects active virus, distinguishes primary vs. reactivation, suitable for immunocompromised | Limited: cannot differentiate past vs. recent infection without avidity testing |
| Regulatory Compliance | DHA Licensed, ISO 9001:2015, UAE PDPL | Standard lab licensing |
Physician Insight & Safety Protocols
โAs a DHA-licensed Consultant Medical Genetics (DHA: 9294403), I emphasize that a positive EBV RNA result confirms active viral replication and must be interpreted alongside clinical symptoms and complementary laboratory markers to ensure diagnostic accuracy. In immunocompromised patients, this molecular assay is indispensable for early detection of EBV-driven lymphoproliferative disorders. The direct detection of viral RNA eliminates the serological window period and provides definitive evidence of active infection.โ โ Lina Osama Zaki Quteineh, Consultant Medical Genetics
Medication Advisory
Do not discontinue prescribed medication or immunosuppressants without consulting your doctor, as this could precipitate disease reactivation or adverse clinical outcomes.
Patient Safety Exclusion Criteria & Emergency Red Flags
- Not suitable for patients with active bleeding disorders or severe thrombocytopenia (platelet count < 20,000/ยตL) without clinical oversight.
- Not indicated for screening of asymptomatic individuals without clinical suspicion; false positives may lead to unnecessary anxiety.
- If you experience severe symptoms such as difficulty breathing, high fever >39.5ยฐC unresponsive to antipyretics, or neurological signs (seizures, altered consciousness), seek immediate emergency care rather than scheduling this test.
Patient FAQ & Clinical Guidance
1. What is the difference between the EBV RNA qualitative test and EBV antibody tests?
The EBV RNA qualitative test directly detects viral RNA, confirming active replication within 24โ48 hours post-collection, while antibody tests detect immune response days to weeks after infection, often missing early primary infection or failing to distinguish reactivation from past exposure.
2. Is home sample collection safe and accurate for this test?
Yes. Our ISO-certified cold-chain home collection ensures sample stability from venipuncture to analysis, preserving RNA integrity and delivering accuracy equivalent to hospital-based draws. VIP mobile phlebotomists adhere to DHA standards and operate daily from 8 AM to 11 PM.
3. How should I prepare for the EBV RNA test and what do the results mean?
No fasting is required; simply sign the consent form and provide a brief clinical history. A positive result indicates active EBV replication necessitating further clinical evaluation, while a negative result rules out current active infection but does not exclude past exposure.
UAE Regulatory & Data Privacy Adherence
This test is processed under DHA Facility License Number 1143 and adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. All laboratory operations maintain ISO 9001:2015 certification.
Clinical & Logistical Metadata
| Test Name | Epstein-Barr Virus (EBV) RNA Qualitative Detection |
| Price (AED) | 700 |
| Turnaround Time | 3rd Working Day (Expedited Email: 36 hours; Phone: 24 hours) |
| Sample Type / Matrix | Whole Blood, Plasma, or Serum |
| Methodology Used | Real-Time PCR & Whole Genome Sequencing |
| ICD-10-CM Code | B27.0, B27.8, B27.9 |
| LOINC Code | 20448-1 |
| DHA Facility License & Laboratory Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians